Pulse Biosciences, Inc.
PLSE
$13.17
-$0.08-0.60%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.13% | -14.13% | 13.36% | -52.88% | -11.39% |
| Total Depreciation and Amortization | -6.23% | -3.53% | -1.39% | -2.38% | -1.34% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.25% | -8.66% | -16.44% | 128.00% | 45.32% |
| Change in Net Operating Assets | -47.39% | 133.42% | -185.26% | 730.26% | -40.44% |
| Cash from Operations | -1.81% | 5.28% | -47.87% | -1.33% | -7.49% |
| Capital Expenditure | 39.81% | -128.89% | 15.09% | -39.47% | -31.03% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Investing | 49.59% | -173.33% | 15.09% | -39.47% | -31.03% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -69.32% | -21.96% | 475,615.38% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -205.36% | 120.14% |
| Cash from Financing | -- | -100.00% | -69.28% | -22.13% | 23,458.11% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.88% | -1,141.90% | -96.82% | -26.18% | 708.09% |